Healthequity (HQY) Liabilities and Shareholders Equity (2014 - 2026)

Healthequity's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $3.3 billion for Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 3.22% year-over-year to $3.3 billion in Q2 2026; TTM through Apr 2026 was $13.5 billion, a 2.64% decrease from a year earlier, with the FY2026 full-year figure at $3.4 billion, down 1.98% from the prior year.
• Liabilities and Shareholders Equity eased to $3.3 billion in Q2 2026 per HQY's latest filing, from $3.4 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $3.5 billion in Q3 2024 and bottomed at $3.0 billion in Q2 2023.
• The 5-year median for Liabilities and Shareholders Equity is $3.2 billion (2024), against an average of $3.2 billion.
• Across the five-year window, Liabilities and Shareholders Equity grew 14.64% in 2022 and slipped 3.22% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $3.1 billion in 2022, then grew by 0.94% to $3.1 billion in 2023, then rose by 12.76% to $3.5 billion in 2024, then fell by 2.59% to $3.4 billion in 2025, then dropped by 2.7% to $3.3 billion in 2026.
• Per Business Quant, the three latest HQY Liabilities and Shareholders Equity figures stand at $3.3 billion (Q2 2026), $3.4 billion (Q1 2026), and $3.4 billion (Q4 2025).